Search Results 1561-1570 of 20001 for Hepatitis b

1. Liver transplant - Doctors & Departments - Mayo Clinic

   Hepatitis B · Hepatitis C · Hepatocellular carcinoma (HCC) · Hilar cholangiocarcinoma · Liver cancer · Liver disease · Liver hemangioma · Living-donor liver ...

2. Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy - Mayo Clinic

   Positive test for hepatitis B virus surface antigen (HBV sAg) or hepatitis C virus ribonucleic acid (HCV RNA), or human immunodeficiency virus (HIV1 or 2) ...

3. Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation - Mayo Clinic

   Known active hepatitis B or hepatitis C infection at the time of screening. 14. A pregnant or lactating woman or a woman who plans to become pregnant during ...

4. Veliparib with or without Carboplatin in Treating Patients with Stage III or Stage IV Breast Cancer - Mayo Clinic

   Patients with an active severe infection; known infection with human immunodeficiency virus (HIV), hepatitis B virus, or hepatitis C virus; HIV patients on ...

5. A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) - Mayo Clinic

   Participant has active hepatitis B infection as determined by NAAT or surface antigen assay. Participants who have acquired immunity from past exposure ...

6. A Study to Evaluate the Impact on NASH with Fibrosis of Obeticholic Acid Treatment - Mayo Clinic

   Participation eligibility · Positive test result at Screening for hepatitis B surface antigen (hBsAg); · Active hepatitis C virus (HCV) infection (positive for ...

7. A Study Of AL101 In Patients with Adenoid Cystic Carcinoma Bearing Activating Notch Mutations - Mayo Clinic

   ... hepatitis B, hepatitis C (HCV), or human immunodeficiency virus (HIV) at Screening (e.g., positive HIV, HBsAg, HCV RNA at screening). Symptomatic central ...

8. A Study to Evaluate the Effect of Olorinab on Gastrointestinal Transit in Patients with Irritable Bowel Syndrome - Mayo Clinic

   Negative hepatitis panel (including hepatitis B surface antigen [HBsAg] and hepatitis C virus antibody [anti-HCV]) and negative for human immunodeficiency ...

9. A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With HIV-1 - Mayo Clinic

   Current hepatitis B virus or hepatitis C virus infection. Female participants must not be pregnant, breastfeeding, or considering becoming pregnant during ...

10. A Study Of The Safety And Effectiveness Of RoActemra/Actemra (Tocilizumab) For Patients With Giant Cell Arteritis - Mayo Clinic

    Positive for hepatitis B or hepatitis C infection. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...